Pushpin-like nanozyme for plasmon-enhanced tumor targeted therapy
Relatively low catalytic activity and poor targeting limit the applications of nanoceria (CeO 2 ) nanozymes in the treatment of tumors. Here, we designed a unique pushpin-like Au/CeO 2 hybrid nanozyme with high catalytic activity by combining site-selective growth and steric restriction strategies. The enhanced enzyme activity was attributed to plasmon-induced hot electrons . Furthermore, the pushpin-like structure facilitated targeting molecule modification. The nanozyme exhibited superior antitumor effects both in vitro and in vivo due to its high catalytic activity and targeting effects. Importantly, its potential mechanism of anti-tumor therapy was studied by quantitative proteomics . The reactive oxygen species (ROS) generated by folic acid-PEG thiol-Au/CeO 2 (FA-Au/CeO 2 ) caused mitochondrial and proteasomal damage in tumor cells and further evoked a response to oxidative stress and innate immunity in vivo . This study provided a spatiotemporal approach to enhance the antitumor activity of nanozymes by structural design. The designed pushpin-like Au/CeO 2 could be utilized as a multifunctional nanoplatform for in vitro and in vivo plasmon-enhanced cancer therapy with active targeting effects. Moreover, this study systematically explored the anti-tumor mechanism of the nanozyme in both cell and mouse models, promoting its translation to the clinic. Statement of significance A strategy combining the principles of site-selective growth and steric restriction was developed to prepare a unique pushpin-like Au/CeO 2 hybrid nanozyme with high catalytic activity and low steric hindrance . The hybrid nanozyme showed superior antitumor activity at both the cellular and tissue levels. Furthermore, the antitumor mechanism was investigated in terms of the differential proteins and their pathways using quantitative proteomics, thus promoting the translation of nanozymes to the clinic.
危险品化学品经营许可证（带存储）